C-myc and IGF-II mRNA-binding protein (CRD-BP/IMP-1) in benign and malignant mesenchymal tumors

被引:61
作者
Ioannidis, P
Trangas, T
Dimitriadis, E
Samiotaki, M
Kyriazoglou, I
Tsiapalis, CM
Kittas, C
Agnantis, N
Nielsen, FC
Nielsen, J
Christiansen, J
Pandis, N
机构
[1] St Savas Hosp, Dept Genet, Athens 11522, Greece
[2] St Savas Hosp, Dept Biochem, Papanikolaou Res Ctr Oncol, Athens, Greece
[3] St Savas Hosp, Dept Orthopaed, Athens, Greece
[4] Univ Athens, Sch Med, Dept Histol & Embryol, Athens, Greece
[5] Sch Med, Dept Pathol, Ioannina, Greece
[6] Rigshosp, Dept Clin Biochem, Copenhagen, Denmark
[7] Univ Copenhagen, Inst Mol Biol, Copenhagen, Denmark
关键词
mRNA-binding protein; c-myc; IGF-II; mesenchymal tumor; c-myc coding region determinant-binding protein; mRNA-binding protein-1;
D O I
10.1002/ijc.1512
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mouse coding region determinant-binding (mCRD-BP) and human IGF-II mRNA-binding 1 (hIMP-1) proteins are orthologous mRNA-binding proteins that recognize c-myc and IGF-II mRNA, respectively, and regulate their expression posttranscriptionally. Here, we confirm that human CRD-BP/IMP-1 binds to c-myc mRNA and that it is predominantly expressed in fetal tissues. Moreover, hCRD-BP/IMP-1 expression was detected in cell lines of neoplastic origin and in selected primary tumors. In a series of 33 malignant and 10 benign mesenchymal tumors, 73% and 40%, respectively, were found to express hCRD-BP/IMP-1. In particular, expression was significant in 14 Ewing's sarcomas, all of which were positive. The data suggest that hCRD-BP/IMP-1 plays a role in abnormal cell proliferation in mesenchymal tumors. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:480 / 484
页数:5
相关论文
共 25 条
[1]   DNA-BINDING AND TRANSCRIPTIONAL ACTIVATION PROPERTIES OF THE EWS-FLI-1 FUSION PROTEIN RESULTING FROM THE T(1122) TRANSLOCATION IN EWING SARCOMA [J].
BAILLY, RA ;
BOSSELUT, R ;
ZUCMAN, J ;
CORMIER, F ;
DELATTRE, O ;
ROUSSEL, M ;
THOMAS, G ;
GHYSDAEL, J .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (05) :3230-3241
[2]  
BARRIOS C, 1994, ONCOLOGY, V51, P13
[3]   CONTROL OF C-MYC MESSENGER-RNA HALF-LIFE INVITRO BY A PROTEIN CAPABLE OF BINDING TO A CODING REGION STABILITY DETERMINANT [J].
BERNSTEIN, PL ;
HERRICK, DJ ;
PROKIPCAK, RD ;
ROSS, J .
GENES & DEVELOPMENT, 1992, 6 (04) :642-654
[4]  
Burrow S, 1998, J SURG ONCOL, V69, P21, DOI 10.1002/(SICI)1096-9098(199809)69:1<21::AID-JSO5>3.0.CO
[5]  
2-M
[6]   Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion [J].
Coller, HA ;
Grandori, C ;
Tamayo, P ;
Colbert, T ;
Lander, ES ;
Eisenman, RN ;
Golub, TR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3260-3265
[7]   Inhibition of c-myc expression in cells by targeting an RNA-protein interaction using antisense oligonucleotides [J].
Coulis, CM ;
Lee, C ;
Nardone, V ;
Prokipcak, RD .
MOLECULAR PHARMACOLOGY, 2000, 57 (03) :485-494
[8]  
Doyle GA, 2000, CANCER RES, V60, P2756
[9]   The c-myc coding region determinant-binding protein:: a member of a family of KH domain RNA-binding proteins [J].
Doyle, GAR ;
Betz, NA ;
Leeds, PF ;
Fleisig, AJ ;
Prokipcak, RD ;
Ross, J .
NUCLEIC ACIDS RESEARCH, 1998, 26 (22) :5036-5044
[10]  
Hassan AB, 2000, CANCER RES, V60, P1070